CombiMatrix to Present at September Investment Conferences

IRVINE, Calif., Sept. 08, 2016 -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announces that management will present at three upcoming investment conferences:

• Rodman & Renshaw 18^th Annual Global Investment Conference on Tuesday, September 13, at 3:25 p.m. Eastern time.  The conference is being held at the Palace Hotel in New York City. 
   
• 2016 Aegis Capital Corp. Growth Conference on Wednesday, September 21, at 8:30 a.m. Pacific time.  The conference is being held at the Encore at Wynn Las Vegas.
   
• Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, at 10:30 a.m. Eastern time.  The conference is being held at the Sofitel Hotel in New York City.

About CombiMatrix Corporation

CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support to foster the highest quality in patient care. CombiMatrix specializes in pre-implantation genetic diagnostics and screening, miscarriage analysis, prenatal and pediatric diagnostics, offering DNA-based testing for the detection of genetic abnormalities beyond what can be identified through traditional methodologies. CombiMatrix performs genetic testing utilizing a variety of advanced cytogenomic techniques, including chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. CombiMatrix is dedicated to providing high-level clinical support for healthcare professionals in order to help them incorporate the results of complex genetic testing into patient-centered medical decision making. Additional information about CombiMatrix is available at www.combimatrix.com or by calling (800) 710-0624.